Strongbridge Biopharma plc.
SBBP
SBBP was delisted on the 5th of October, 2021.
18 hedge funds and large institutions have $51.6M invested in Strongbridge Biopharma plc. in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
60.84% more ownership
Funds ownership: 0% → 60.84% (+61%)
23% more capital invested
Capital invested by funds: $41.8M → $51.6M (+$9.75M)
20% more funds holding
Funds holding: 15 → 18 (+3)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$21.9M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$12.2M |
| 3 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$8.15M |
| 4 |
BC
Broadfin Capital
New York
|
+$5.05M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$907K |
| 2 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$403K |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$6.01K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4K |
SBBP Hedge Fund Activity: Q4 2016 in Review
18 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q4 2016, worth a combined $51.6M — up 23% from $41.8M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SBBP positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Caxton Corporation, adding an estimated $21.9M. The largest seller was RA Capital Management, cutting an estimated $907K.
- 18 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q4 2016, up from 15 in Q3 2016.
- Funds reported $51.6M of Strongbridge Biopharma plc. stock for Q4 2016, up 23% quarter-over-quarter.
- 6 funds opened new Strongbridge Biopharma plc. positions in Q4 2016 and 2 closed out, a net change of +4 holders.
- The largest Strongbridge Biopharma plc. buyer in Q4 2016 was Caxton Corporation, an estimated $21.9M added.
- The largest Strongbridge Biopharma plc. seller in Q4 2016 was RA Capital Management, an estimated $907K sold.
Based on aggregated 13F filings for Q4 2016.